Form4insider filings, from the source

SEC Form 4 · accession 0001140361-18-019794

Orexigen Therapeutics, Inc. · OREXQ

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Apr 13, 2018
Accepted (ET)
Apr 26, 2018 · 4:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001382911

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
0% Senior Secured Convertible Notes due 2020F3,F4,F1,F2$7.50Apr 13, 2018J16,483,517DSep 21, 2016Jun 29, 2020Common Stock2,197,8027,802,197I

Explanation of responses